Relmada Therapeutics
RLMD
#6663
Rank
โ‚น70.59 B
Marketcap
โ‚น673.04
Share price
-0.07%
Change (1 day)
1,097.48%
Change (1 year)

Revenue for Relmada Therapeutics (RLMD)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Relmada Therapeutics from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2017 N/A
2016 N/A
2015 N/A
2013 โ‚น0.29 M-45.99%
2012 โ‚น0.55 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Cytokinetics
CYTK
โ‚น10.12 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
โ‚น58.43 BN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel